Citation | DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem57:2601-10 (2014) [PubMed] Article |
---|
SMILES | C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)c(Cl)c1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:10.14,1.0,wD:7.8,c:5,(59.7,-43.26,;61.02,-42.48,;60.97,-40.94,;62.18,-39.99,;63.65,-40.41,;61.65,-38.54,;60.1,-38.61,;59.69,-40.08,;58.5,-39.1,;57.05,-39.63,;56.79,-41.15,;57.98,-42.13,;59.42,-41.6,;55.35,-41.68,;54.17,-40.69,;53.9,-42.21,;55.09,-43.2,;62.42,-37.21,;63.96,-37.23,;64.74,-35.9,;63.98,-34.56,;64.76,-33.23,;62.43,-34.55,;61.67,-33.21,;61.66,-35.88,;62.34,-43.26,;62.32,-44.81,;63.65,-45.59,;64.99,-44.84,;65.01,-43.3,;63.69,-42.52,;66.32,-45.63,;66.3,-47.17,;67.66,-44.88,;68.98,-45.66,;70.32,-44.91,;71.65,-45.69,;72.99,-44.94,;71.63,-47.23,)| |